位置:首页 > 蛋白库 > EVL_XENLA
EVL_XENLA
ID   EVL_XENLA               Reviewed;         692 AA.
AC   Q64GL0; Q64GL1; Q64GL2;
DT   17-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2004, sequence version 1.
DT   03-AUG-2022, entry version 78.
DE   RecName: Full=Ena/VASP-like protein;
DE   AltName: Full=Ena/vasodilator-stimulated phosphoprotein-like;
GN   Name=evl {ECO:0000250|UniProtKB:P70429};
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAU20373.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Embryo {ECO:0000269|PubMed:15661649};
RX   PubMed=15661649; DOI=10.1016/j.modgep.2004.09.004;
RA   Wanner S.J., Danos M.C., Lohr J.L., Miller J.R.;
RT   "Molecular cloning and expression of Ena/Vasp-like (Evl) during Xenopus
RT   development.";
RL   Gene Expr. Patterns 5:423-428(2005).
CC   -!- FUNCTION: Ena/VASP proteins are actin-associated proteins involved in a
CC       range of processes dependent on cytoskeleton remodeling and cell
CC       polarity such as axon guidance and lamellipodial and filopodial
CC       dynamics in migrating cells. Evl enhances actin nucleation and
CC       polymerization (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P70429}. Cytoplasm, cytoskeleton, stress fiber
CC       {ECO:0000250|UniProtKB:P70429}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:P70429}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3 {ECO:0000269|PubMed:15661649}; Synonyms=H
CC       {ECO:0000269|PubMed:15661649};
CC         IsoId=Q64GL0-1; Sequence=Displayed;
CC       Name=1 {ECO:0000269|PubMed:15661649};
CC         IsoId=Q64GL0-3; Sequence=VSP_052379, VSP_052380;
CC       Name=2 {ECO:0000269|PubMed:15661649}; Synonyms=I
CC       {ECO:0000269|PubMed:15661649};
CC         IsoId=Q64GL0-2; Sequence=VSP_052379, VSP_052380, VSP_052381;
CC   -!- TISSUE SPECIFICITY: During embryonic and tadpole development, expressed
CC       in the cement gland, brain, neural tube, myotome and neural placodes,
CC       including the otic, lateral line and olfactory placodes. All isoforms
CC       show similar spatial expression patterns.
CC       {ECO:0000269|PubMed:15661649}.
CC   -!- DEVELOPMENTAL STAGE: First expressed at stage 18. Expression increases
CC       through the early tailbud stage (stage 23) and remains relatively high
CC       throughout the remainder of development. All isoforms show similar
CC       temporal expression patterns. {ECO:0000269|PubMed:15661649}.
CC   -!- DOMAIN: The EVH2 domain is comprised of 3 regions. Block A is a
CC       thymosin-like domain required for G-actin binding. The KLKR motif
CC       within this block is essential for the G-actin binding and for actin
CC       polymerization. Block B is required for F-actin binding and subcellular
CC       location, and Block C for tetramerization. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the Ena/VASP family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY686697; AAU20371.1; -; mRNA.
DR   EMBL; AY686698; AAU20372.1; -; mRNA.
DR   EMBL; AY686699; AAU20373.1; -; mRNA.
DR   RefSeq; NP_001089020.1; NM_001095551.1. [Q64GL0-1]
DR   AlphaFoldDB; Q64GL0; -.
DR   SMR; Q64GL0; -.
DR   MaxQB; Q64GL0; -.
DR   PRIDE; Q64GL0; -.
DR   GeneID; 496406; -.
DR   KEGG; xla:496406; -.
DR   CTD; 496406; -.
DR   Xenbase; XB-GENE-988627; evl.L.
DR   OrthoDB; 972128at2759; -.
DR   Proteomes; UP000186698; Chromosome 8L.
DR   Bgee; 496406; Expressed in brain and 17 other tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005925; C:focal adhesion; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005522; F:profilin binding; ISS:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; ISS:UniProtKB.
DR   GO; GO:0045010; P:actin nucleation; IEA:InterPro.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; ISS:UniProtKB.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR034319; ENA/VASP-like_protein.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR038023; VASP_sf.
DR   InterPro; IPR014885; VASP_tetra.
DR   InterPro; IPR000697; WH1/EVH1_dom.
DR   PANTHER; PTHR11202:SF4; PTHR11202:SF4; 1.
DR   Pfam; PF08776; VASP_tetra; 1.
DR   Pfam; PF00568; WH1; 1.
DR   SMART; SM00461; WH1; 1.
DR   SUPFAM; SSF118370; SSF118370; 1.
DR   PROSITE; PS50229; WH1; 1.
PE   2: Evidence at transcript level;
KW   Actin-binding; Alternative splicing; Cell projection; Cytoplasm;
KW   Cytoskeleton; Reference proteome; SH3-binding.
FT   CHAIN           1..692
FT                   /note="Ena/VASP-like protein"
FT                   /id="PRO_0000284709"
FT   DOMAIN          1..112
FT                   /note="WH1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00410"
FT   REGION          116..310
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          466..518
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          522..689
FT                   /note="EVH2"
FT                   /evidence="ECO:0000255"
FT   REGION          522..542
FT                   /note="EVH2 block A"
FT                   /evidence="ECO:0000255"
FT   REGION          531..650
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          563..580
FT                   /note="EVH2 block B"
FT                   /evidence="ECO:0000255"
FT   REGION          655..689
FT                   /note="EVH2 block C"
FT                   /evidence="ECO:0000255"
FT   MOTIF           531..534
FT                   /note="KLKR"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        116..136
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        139..153
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        154..194
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        208..270
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        277..310
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        478..507
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        542..558
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        570..597
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        598..622
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         162
FT                   /note="V -> G (in isoform 1 and isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15661649"
FT                   /id="VSP_052379"
FT   VAR_SEQ         163..456
FT                   /note="Missing (in isoform 1 and isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15661649"
FT                   /id="VSP_052380"
FT   VAR_SEQ         639
FT                   /note="R -> RTPPVVKSPEAKSPIQSQPPSR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15661649"
FT                   /id="VSP_052381"
SQ   SEQUENCE   692 AA;  73921 MW;  FE7505502E8BE9EC CRC64;
     MSEQSICQAR ASVMIYDDTS KKWVPIKPGQ QGFSRINIYH NTANNTFRVV GVKLQDQQVV
     INYSLVKGLK YNQATPTFHQ WRDARQVYGL NFASKEEATT FSNAMLFALN IMNSQDGGPA
     AQRQAQNIQN GPSPDDMEIQ RRQMLEQQQR QETLERRTST TVSTLQINVS SSPSHCQSPP
     PDYSNFSASP STGAVPPPSY AKVISSAAAS PELSSKSTNK SSNRTSEPPE LQNSHCGSEP
     STSQSSAFSP IRPSNGTVSR SIKQISLSPP PAPGSHSPLS LHQSVRHPSL SFSPCSSSPP
     VSVTSSVQKN ISPQSPIPVV LPVIPVQNSR IRGCSDKMVQ NPIVPQTGPS DQAEEPLTSQ
     ISLSSPRTQV KCVDRSFLSY IETVPVAQLP MITSPFGILT QASPQPFQSS THPSQQSYQS
     MSHFVSLPPP YAAVSELTLP KRTTPYMTSS TITQFSPVLP PGHPSSAAMV ASVGSAPAPA
     SGPPPPPPPG PPPPSGGTPP PAPPLPAGGS QGVVYEESPA SGLAAALAGA KLRKVQRPED
     GSSSPCGATK TDANRTSSGG GGGGLMEEMN KLLAKRRKAA SYTDKPGDKK EEECQNEDAS
     LSSSPVTRGP TPQNSSDLGK KPWERSNSVE KPVPSLLSRM KPVSSSNDVS TDALDFDRMK
     QEILEEVVRE LHKVKEEIID AIRQELSRIS TT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024